King Hussein Cancer Center says coming years hold promise for patients

2. Picture
King Hussein Cancer Center. (Photo: JNews)
AMMAN — Director-General of the King Hussein Cancer Center Asem Al-Mansour said that a drug used in a trial therapy which cured rectal cancer in patients is promising, according to a local news outlet.اضافة اعلان

A group of 18 people were administered the drug, called Dostarlimab, for six months and it was seen that the tumors had disappeared, according to last week’s news reports in US medical journals, which called the drug “miraculous”. The patients had rectal cancer.

Mansour said Monday that during the next two to three years, there will be accurate treatments for many types of cancer targeting a specific mutation with a very high response rate, and with minor side effects.

Mansour noted that these treatments are very expensive, and their value may reach $7,000 to 10,000 per month, and that they will be given for at least six months. He suggested that many countries may be unable to afford this drug, unless there is a serious global movement that forces pharmaceutical companies to help patients.

Read more National news
Jordan News